Revance Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 8.73 M | $45.30 M | 100.00% | 8.37% |
| VANGUARD GROUP INC | 11/13/2024 | 5.73 M | $29.76 M | -4.35% | 5.50% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 4.78 M | $24.59 M | -23.55% | 4.59% |
| FIL LTD | 11/13/2024 | 4.19 M | $21.76 M | 100.00% | 4.02% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 11/08/2024 | 4.16 M | $21.61 M | 100.00% | 3.99% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 3.26 M | $16.92 M | 2,600.85% | 3.13% |
| MAGNETAR FINANCIAL LLC | 11/13/2024 | 2.50 M | $12.98 M | 100.00% | 2.40% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 2.50 M | $12.98 M | 525.00% | 2.40% |
| STATE STREET CORP | 11/14/2024 | 2.43 M | $12.63 M | 6.58% | 2.34% |
| WATER ISLAND CAPITAL LLC | 11/14/2024 | 2.38 M | $12.36 M | 100.00% | 2.28% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 2.31 M | $11.99 M | 100.00% | 2.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.29 M | $11.89 M | -0.36% | 2.20% |
| LMR PARTNERS LLP | 11/07/2024 | 2.24 M | $11.65 M | 100.00% | 2.15% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 1.93 M | $10.03 M | 1,689.41% | 1.85% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 1.89 M | $9.82 M | 100.00% | 1.81% |
| KRYGER CAPITAL LTD | 11/14/2024 | 1.67 M | $8.65 M | 100.00% | 1.60% |
| PALO ALTO INVESTORS LP | 11/14/2024 | 1.61 M | $8.37 M | -69.34% | 1.55% |
| AQR ARBITRAGE LLC | 11/14/2024 | 1.41 M | $7.33 M | 100.00% | 1.36% |
| MADISON AVENUE PARTNERS, LP | 11/14/2024 | 1.35 M | $7.02 M | 100.00% | 1.30% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.16 M | $6.04 M | 24.61% | 1.12% |
| GABELLI FUNDS LLC | 11/13/2024 | 1.09 M | $5.66 M | 100.00% | 1.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 1.05 M | $5.45 M | 100.00% | 1.01% |
| MORGAN STANLEY | 11/14/2024 | 867,127 | $4.50 M | -11.25% | 0.83% |
| GABELLI & CO INVESTMENT ADVISERS, INC. | 11/13/2024 | 839,800 | $4.36 M | 100.00% | 0.81% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2024 | 820,000 | $4.26 M | -70.71% | 0.79% |
| WOODLINE PARTNERS LP | 11/14/2024 | 797,953 | $4.14 M | 100.00% | 0.77% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 790,837 | $4.10 M | 5.50% | 0.76% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/28/2024 | 730,190 | $3.79 M | 2.54% | 0.70% |
| 12/03/2024 | 725,000 | $3.76 M | 100.00% | 0.70% | |
| WALLEYE CAPITAL LLC | 11/14/2024 | 699,621 | $3.63 M | 14.54% | 0.67% |
| UBS GROUP AG | 11/14/2024 | 632,553 | $3.28 M | 1,145.85% | 0.61% |
| JANE STREET GROUP, LLC | 11/15/2024 | 568,654 | $2.95 M | 246.92% | 0.55% |
| MARSHALL WACE, LLP | 11/14/2024 | 567,300 | $2.94 M | 100.00% | 0.54% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 11/14/2024 | 522,716 | $2.71 M | 1,231.15% | 0.50% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 459,300 | $2.38 M | -19.70% | 0.44% |
| ESSEX WOODLANDS MANAGEMENT, INC. | 11/14/2024 | 457,085 | $2.37 M | 0.00% | 0.44% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 455,313 | $2.36 M | -56.89% | 0.44% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 446,027 | $2.31 M | 100.00% | 0.43% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 418,200 | $2.17 M | 100.00% | 0.40% |
| EXOME ASSET MANAGEMENT LLC | 12/13/2024 | 347,600 | $1.80 M | 100.00% | 0.33% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 326,283 | $1.69 M | -12.53% | 0.31% |
| MAN GROUP PLC | 11/14/2024 | 300,000 | $1.56 M | 100.00% | 0.29% |
| BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 11/12/2024 | 283,800 | $1.46 M | 100.00% | 0.27% |
| OPALEYE MANAGEMENT INC. | 11/14/2024 | 275,000 | $1.43 M | 100.00% | 0.26% |
| ALPHACENTRIC ADVISORS LLC | 10/30/2024 | 245,000 | $1.27 M | 0.00% | 0.24% |
| ALBERTA INVESTMENT MANAGEMENT CORP | 11/05/2024 | 240,000 | $1.25 M | 100.00% | 0.23% |
| WOLVERINE ASSET MANAGEMENT LLC | 11/04/2024 | 231,400 | $1.20 M | 9,141.21% | 0.22% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 230,609 | $1.20 M | 100.00% | 0.22% |
| FMR LLC | 11/13/2024 | 214,596 | $1.11 M | 28.63% | 0.21% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 203,200 | $1.05 M | 100.00% | 0.20% |
Revance Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 278 institutional investors and hedge funds held shares of Revance Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 8.73 M
VANGUARD GROUP INC: 5.73 M
FRANKLIN RESOURCES INC: 4.78 M
FIL Ltd: 4.19 M
ALPINE ASSOCIATES MANAGEMENT INC.: 4.16 M
ALLIANCEBERNSTEIN L.P.: 3.26 M
79.30% of Revance Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 96.12 M shares in the last 24 months. This purchase volume represents approximately $293.16 M in transactions.